U.S. Epigenetics Market Size Witnesses Robust Growth Rate of CAGR 19.1%, Exceeding USD 2,845 Million

BROOKLYN, N.Y. - Dec. 16, 2024 - PRLog -- According to the latest report by IMARC Group, the epigenetics market size in the U.S. reached USD 592 million in 2024, with projections indicating it will grow to USD 2,845 million by 2033, reflecting a CAGR of 19.1% from 2025 to 2033.

U.S. Epigenetics Industry Trends & Drivers:
The United States epigenetics market is experiencing a surge in innovation and adoption due to the increasing focus on precision medicine and personalized healthcare. Advances in epigenetic research are driving the development of novel diagnostic tools and therapeutic solutions that target epigenetic modifications, offering new opportunities in oncology, cardiovascular diseases, and neurological disorders. The integration of next-generation sequencing (NGS) technologies and artificial intelligence (AI) is enhancing the understanding of epigenomic landscapes, enabling more accurate predictions of disease susceptibility and treatment outcomes.

The rising demand for non-invasive diagnostics, such as liquid biopsy methods, is further shaping the market, as epigenetic biomarkers gain prominence in early detection and monitoring. Additionally, pharmaceutical companies are intensifying their efforts in epigenetic drug development, focusing on therapies that can regulate gene expression and modulate the epigenome effectively. Regulatory support and increasing investment in research and development (R&D) are creating a robust pipeline of products, ensuring long-term market growth.

The growing prevalence of chronic diseases, particularly cancer, is a major driver of the United States epigenetics market. Epigenetic modifications, such as DNA methylation and histone acetylation, are critical in the pathogenesis of many cancers, prompting significant research and investment in epigenetic diagnostics and therapies. The shift toward precision medicine is also accelerating market growth, as epigenetic tools are increasingly recognized for their role in tailoring treatments to individual genetic and epigenetic profiles.

Get a sample copy of the report: https://www.imarcgroup.com/united-states-epigenetics-market/requestsample

United States Epigenetics Industry Segmentation:
Product Insights:

• Reagents
• Kits
  • Chip Sequencing Kit
  • Whole Genomic Amplification Kit
  • Bisulfite Conversion Kit
  • RNA Sequencing Kit
  • Others
• Instruments
• Enzymes
• Services

Technology Insights:

• DNA Methylation
• Histone Methylation
• Histone Acetylation
• Large Non-Coding RNA
• MicroRNA Modification
• Chromatin Structures

Application Insights:

• Oncology
  • Solid Tumors
  • Liquid Tumors
• Non-Oncology
  • Inflammatory Diseases
  • Metabolic Diseases
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Regional Insights:

• Northeast
• Midwest
• South
• West

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.

Browse the Full Report: https://www.imarcgroup.com/united-states-epigenetics-market